Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
BRC Group Holdings, Inc. Reports First Quarter 2026 Financial Results
-
Perdoceo Education Corporation Announces First Quarter 2026 Results
-
Consensus Cloud Solutions, Inc. Reports First Quarter 2026 Results; Reaffirms Full Year 2026 and Releases Q2 2026 Guidance
-
Ross Stores, Inc. Announces First Quarter 2026 Earnings Release and Conference Call
-
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
-
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results
-
The Trade Desk Reports First Quarter 2026 Financial Results
-
Bluejay Diagnostics Provides First Quarter 2026 Corporate Update
-
OpenText Reports Third Quarter Fiscal Year 2026 Financial Results
-
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
-
Nerdy Announces First Quarter 2026 Financial Results
-
Maravai LifeSciences Reports First Quarter 2026 Financial Results
-
Celldex Reports First Quarter Financial Results and Provides Corporate Update
-
Janux Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights
-
Arcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress
-
VTEX Reports First Quarter 2026 Financial Results
-
Arrowhead Pharmaceuticals Reports Fiscal 2026 Second Quarter Results
-
Stoke Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Updates
-
Amneal Reports First Quarter 2026 Financial Results
-
Personalis Reports First Quarter Results and Recent Highlights
-
Progyny, Inc. Announces First Quarter 2026 Results
-
Turtle Beach Corporation Announces First Quarter 2026 Results
-
Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
-
Denali Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights
-
Greenland Mines Reports Up To 45% – 55% Increase in Palladium Equivalent (PdEq) Grades at Skaergaard in Sensitivity Study
-
Gevo Announces First Quarter 2026 Results and Provides Update on Expansion and Alcohol-to-Jet Project
-
First Quantum Minerals Announces Voting Results for the Election of Directors
-
Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones
-
SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update
-
Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results
-
AN2 Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum
-
BridgeBio Reports First Quarter 2026 Financial Results and Corporate Updates
-
Prairie Operating Co. Announces First Quarter 2026 Earnings Release Date and Conference Call
-
Xenon Reports Q1 2026 Financial Results and Provides Business Update
-
Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights
-
ParkerVision Reports First Quarter 2026 Results
-
Newsmax Audience Surges in April, Hits Records in Growth
-
Research Frontiers Reports First Quarter 2026 Financial Results and Will Host a Conference Call at 4:30 p.m. Today
-
California American Water and the American Water Charitable Foundation Provide Over $1 Million in Statewide Support to Communities in 2025
-
Amtech Systems Reports Fiscal 2026 Second Quarter Financial Results
-
ASCENT RESOURCES REPORTS FIRST QUARTER 2026 OPERATING AND FINANCIAL RESULTS AND PROVIDES 2026 NGL GUIDANCE DETAIL
-
Gabe Camarillo Joins Peraton as Defense Sector President, Furthering the Company’s Commitment to Supporting Critical Missions of Consequence
-
Expensify Announces Q1 2026 Results
-
Blend Announces First Quarter 2026 Financial Results
-
Univar Solutions Announces Leadership Evolution
-
Corsair Reports Strong Profit Growth for First Quarter 2026
-
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial Results
-
Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress
-
Novavax to Participate in BofA Securities 2026 Health Care Conference
-
Aptar Pharma Announces Progress on Multi-Year U.S. FDA-Funded Research Contract

